Trump - MM+M - Medical Marketing and Media

Trump

All articles by Trump

Communicating in the Aftermath of ‘Repeal and Replace’
Communicating in the Aftermath of ‘Repeal and Replace’
Brittney Manchester
March 8, 2018
12:00 pm

Today’s effective communicators must be comfortable with change, learn how to anticipate it, and adapt messaging to key audiences.

Five things for pharma marketers to know: Thursday, January 11, 2018
Five things for pharma marketers to know: Thursday, January 11, 2018
Virginia Lau
January 11, 2018
3:20 pm

Novartis Oncology taps Pfizer exec as CEO; healthcare jobs become the largest source of U.S. employment; HHS nominee wary about drug-pricing negotiations

From working for one administration to fending off another: Planned Parenthood’s Kevin Griffis
From working for one administration to fending off another: Planned Parenthood’s Kevin Griffis
Alison Kanski
January 4, 2018
3:35 pm

Kevin Griffis brought his experience in government and politics to Planned Parenthood at the perfect time, leading the fight to protect birth control coverage under the Trump administration and destigmatizing abortion.

Gottlieb Eyes Prices, Not Lives
Gottlieb Eyes Prices, Not Lives
Sander Flaum, Flaum Navigators
December 14, 2017
12:00 pm

It turns out the real goal is going after Washington’s favorite whipping boy — high drug prices.

Tax Bill Is Good News for Life Sciences and Marketing
Tax Bill Is Good News for Life Sciences and Marketing
John Kamp, Coalition for Healthcare Communication.
December 11, 2017
12:00 pm

Although it’s a long way from the president’s desk, the Tax Cut and Jobs Act of 2017 contains plenty of good news for the life sciences industry and its marketing partners.

How will the pharma industry fare in 2018 under Trump?
How will the pharma industry fare in 2018 under Trump?
Larry Dobrow
December 5, 2017
3:35 pm

The first year of the Trump administration was kind to pharma, but it might not be so fortunate in 2018.

Five things for pharma marketers to know: Tuesday, October 31, 2017
Five things for pharma marketers to know: Tuesday, October 31, 2017
Virginia Lau
October 31, 2017
2:37 pm

Pfizer Q3 revenue driven by Prevnar sales; President Trump’s opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah

Who’s Getting Rich in Healthcare?
Who’s Getting Rich in Healthcare?
Sander Flaum, Flaum Navigators
October 30, 2017
11:00 am

Do you recall what President Trump tweeted right after Merck’s Kenneth Frazier resigned from his American Manufacturing Council?

Snubbing Intolerance: Frazier’s Path Was Disengagement
Snubbing Intolerance: Frazier’s Path Was Disengagement
Marc Iskowitz
September 1, 2017
11:00 am

Merck CEO Kenneth Frazier’s exit from a presidential manufacturing council may go down as one of the most principled stands by the CEO of a major U.S. company, let alone a drugmaker.

Frazier’s call earns him praise, rare for a pharma CEO
Frazier’s call earns him praise, rare for a pharma CEO
Jaimy Lee
August 15, 2017
8:00 pm

It’s not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners